News Article

German healthcare operator Schön Klinik Group has announced its complete withdrawal from the United Kingdom market to refocus on its core domestic operations. 

The strategic exit marks the end of an eight-year presence in the country for the Germany-based hospital network.

The decision follows a comprehensive portfolio review and will see the group divest its remaining specialised mental health and care assets, including the Chelsea eating disorder clinic and the York dementia care facility. This final withdrawal concludes a phased retreat that began in May 2023, when the operator sold its flagship orthopaedic hospital in central London to Affidea-owned Fortius Clinic.

Prior to the full market exit announcement, the group had been focusing on mental health and neuro-rehabilitation, but the UK operations consistently represented a marginal fraction of the group’s total revenue compared to its seventeen hospitals and numerous outpatient centres in Germany.

For investors and healthcare operators, the exit underscores a broader trend of cross-border operators retreating to their primary markets to consolidate capital and management bandwidth. Schön Klinik is majority-owned by the founding family alongside a minority twenty-three percent stake held by The Carlyle Group.

The departure of Schön Klinik leaves further room for domestic consolidation within the UK private hospital market.  As the sale processes for the remaining mental health sites conclude, the group is expected to transition current patients to alternative private providers to ensure continuity of care.